Paul H. Klingenstein
Mr. Paul Klingenstein "has been a venture capital investor for most of his professional career. Beginning at Warburg, Pincus in the early 1980s, he joined Accel Partners in 1986 and helped, through the next decade, to build a leading venture capital firm. After a brief period as an advisor to the Rockefeller Foundation, he formed Aberdare Ventures in 1999. During this period he has been an active participant in more than 40 companies, the majority of which are now public, or have been merged into public companies. These investments comprise mostly early-stage domestic businesses, but also include later-stage, public, and non-U.S. companies, and management buyouts. His current and former boards include Alibris, Ample Medical, Anacor Pharmaceuticals, Aviron, EP Technologies, Idun Pharmaceuticals, Isis Pharmaceuticals, Posit Science, Pharmion, Salmedix, US Behavioral Health, and Xomed Surgical Products. He has served on the boards of various educational and nonprofit institutions including the African Wildlife Foundation, Juma Ventures, the Marin Country Day School, and The Taft School. He received an AB from Harvard and an MBA from Stanford." [1]
- Director, International AIDS Vaccine Initiative
